Market Cap 43.41B
Revenue (ttm) 7.88B
Net Income (ttm) 1.15B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 28.06
Profit Margin 14.53%
Debt to Equity Ratio 0.46
Volume 49,400
Avg Vol 74,188
Day's Range N/A - N/A
Shares Out 702.29M
Stochastic %K 50%
Beta 1.14
Analysts Strong Sell
Price Target $79.50

Company Profile

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operate...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 41 61 316 81 11
Address:
Muenchensteinerstrasse 38, Basel, Switzerland
Latest News on LZAGY
No data available.